Oral Reduced L-Glutathione Improves Growth in Pediatric Cystic Fibrosis Patients: A Randomized Clinical Trial.
primary studies published RCT
Details- 2015
- Visca A
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
primary studies published RCT
Details- 2015
- Wainwright CE
Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis.
primary studies published RCT
Details- 2015
- Wheatley CM
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.
primary studies published RCT
Details- 2015
- Yau YC
Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data.
primary studies published RCT
Details- 2014
- Accurso FJ
Nebulized tobramycin in the treatment of adult cf pulmonary exacerbations.
primary studies published RCT
Details- 2014
- Al-Aloul M
Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; A randomized controlled clinical trial.
primary studies published RCT
Details- 2014
- Bakker EM
Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
primary studies published RCT
Details- 2014
- Ballmann M
Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: Efficacy of a nutrition intervention.
primary studies published RCT
Details- 2014
- Bertolaso C
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
primary studies published RCT
Details- 2014
- Boyle MP